# Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models

> **NCT07732933** · NA · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 20 (estimated)

## Conditions studied

- Bipolar Disorder (BD)
- Bipolar Disorder (BPD)

## Interventions

- **PROCEDURE:** Peripheral blood sampling for PBMC isolation

## Key facts

- **NCT ID:** NCT07732933
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2029-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07732933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07732933, "Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07732933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*